United States · FDA National Drug Code directory
MOVANTIK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57841-1301_27e98e6d-9faf-3a94-e063-6394a90a1dcb
- Product NDC
- 57841-1301
- Form
- TABLET, FILM COATED
- Composition / generic term
- naloxegol oxalate
- Labeler
- RedHill Biopharma Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201001 / 20270131
Source-listed ingredients
- NALOXEGOL OXALATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (57841-1301-1) · 57841-1301-1
- 90 TABLET, FILM COATED in 1 BOTTLE (57841-1301-2) · 57841-1301-2
- 10 BLISTER PACK in 1 CARTON (57841-1301-3) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 57841-1301-3
- 1 BLISTER PACK in 1 CARTON (57841-1301-4) / 3 TABLET, FILM COATED in 1 BLISTER PACK · 57841-1301-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →